$16.31
0.000500.00%
Pre-Market: Dec 20, 4:01 PM EDT
Anika Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Anika Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-31 | $-0.25 | $-0.01 | -2400.0 % |
Jun 2024 | 2024-08-08 | $0.17 | $0.05 | 240.0 % |
Mar 2024 | 2024-05-08 | $0.09 | $-0.19 | 147.4 % |
Dec 2023 | 2024-03-13 | $0.05 | $-0.26 | 119.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-31 | $38.75M | $42.08M | -7.91 % |
Jun 2024 | 2024-08-08 | $41.92M | $42.10M | -0.43 % |
Mar 2024 | 2024-05-08 | $40.52M | $39.14M | 3.53 % |
Dec 2023 | 2024-03-13 | $42.97M | $41.40M | 3.79 % |
Anika Therapeutics (ANIK) is scheduled to report earnings on March 12, 2025. The last reported earnings were for reported on October 31, 2024 for Q3.
The Actual EPS was $-0.25, which missed the estimate of $-0.01.
The Actual Revenue was $38.8M, which missed the estimate of $42.1M.
Browse earnings estimates, EPS, and revenue on all stocks.